Literature DB >> 9029760

Determination of rapamycin in whole blood by HPLC.

J O Svensson1, C Brattström, J Säwe.   

Abstract

Sirolimus (rapamycin, RAPA) is a natural fermentation product (macrolide antibiotic) that has demonstrated potent immunosuppressive activity. A reverse-phase high-performance liquid chromatographic (HPLC) method is described for analysis of the drug in whole blood. The samples are purified by using liquid-liquid extraction with butyl chloride/diethyl ether combined with reversed-phase solid-phase extraction. RAPA and internal standard were traced by UV-detection at 278 nm. Linear calibration curves with correlation coefficients > 0.999 were obtained (range, 1-50 ng/ml). Minimum detectable concentration was approximately 0.4 ng/ml and recovery approximately 45% for both RAPA and internal standard. Coefficient of variation (day to day) was 9.8% at 5 ng/ml (n = 6) and 5.6% at 40 ng/ml (n = 6). The chromatography requires < 10 min per sample. The assay has proved to be free of interference peaks from cyclosporine or tacrolimus. The method has been used to determine the whole blood concentrations in samples from healthy volunteers and renal transplant recipients receiving single and multiple doses of oral rapamycin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029760     DOI: 10.1097/00007691-199702000-00022

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  2 in total

Review 1.  Clinical pharmacokinetics of sirolimus.

Authors:  K Mahalati; B D Kahan
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.